Home / Inspections / 1100022

FDA Inspection 1100022 — Azurity Pharmaceuticals, Inc.

Azurity Pharmaceuticals, Inc. — FEI 3003395329

The FDA completed an inspection of Azurity Pharmaceuticals, Inc. on July 26, 2019 in Woburn, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 26, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Woburn, MA (United States)

Facility

Other inspections at this facility

  • 1297348 (NAI Fri Dec 12 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1163010 (VAI Thu Feb 24 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 970690 (NAI Tue Apr 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 865746 (VAI Wed Jan 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 655593 (NAI Fri Mar 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources